Main problems and countermeasures of ophthalmic
artificial intelligence research

doi:10.13281/j.cnki.issn.1004-4469.2021.02.001

Ophthalmology in China ›› 2021, Vol. 30 ›› Issue (2): 81-84.doi: 10.13281/j.cnki.issn.1004-4469.2021.02.001

Previous Articles Next Articles

Main problems and countermeasures of ophthalmic artificial intelligence research

Wang Yaxing¹, Xue Cancan^1,2, Li Jianjun¹

¹Beijing Tongren Eye Center, Beijing Tongren Hospital,Beijing Institute of Ophthalmology, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100005, China; ² Department of Ophthalmology, the Third Hospital of Peking University, Beijing 100191, China

Received:2021-02-09 Online:2021-03-25 Published:2021-03-26
Contact: Wang Yaxing, Email: yaxingw@gmail.com
Supported by:
Beijing Municipal of Health Reform and Development Project (2019-4)

Abstract

Abstract:

With the advent of artificial intelligence (AI) and its implication in medical field in recent years, AI in ophthalmology has been a trending topic. In case of major vision-threatening diseases, like diabetic retinopathy, glaucoma, and age-related macular degeneration, AI-related researches have emerged expansively. Despite much promising research currently being undertaken, general issues exist, like being lack of transparency, clear reporting to facilitate replicability, and clear demonstrations of effectiveness. This article described the challenges and unmet needs for AI application in major eye diseases and the common conditions in the field, and additionally introduced guidelines to regulate AI researches in ophthalmology and health care. （Ophthalmol CHN, 2021, 30: 81-84）

Key words:

artificial intelligence, diabetic retinopathy, age-related macular degeneration, glaucoma, standardization

Wang Yaxing, Xue Cancan, Li Jianjun.

Main problems and countermeasures of ophthalmic artificial intelligence research [J]. Ophthalmology in China, 2021, 30(2): 81-84.

[1]	Chen Changxi, Wang Jinda, Cao Kai, Xu Liang, Wang Yaxing, Li Jianjun . Anterior chamber volume measurement and its value of screening primary angle-closure glaucoma in adults over 45 years old: The Beijing Eye Study [J]. Ophthalmology in China, 2021, 30(4): 259-264.
[2]	Pei Xueting, Fan Zhigang, Qing Guoping, Li Dongjun, Wang Shuhua . Biometric characteristics of primary angle closure glaucoma with zonular abnormality found during cataract surgery [J]. Ophthalmology in China, 2021, 30(4): 264-269.
[3]	Jia Liyun, Zhang Yongpeng, Ma Kai. Efficacy of vitrectomy combined with internal limiting membrane peeling for proliferative diabetic retinopathy with macular detachment [J]. Ophthalmology in China, 2021, 30(3): 222-226.
[4]	Chen Changxi, Cao Kai, Wang Jinda, Li Jianjun, Xu Liang, Wang Yaxing. Distribution of lens vault and its correlation with primary angle-closure glaucoma in people over 45 years old: Beijing Eye Study [J]. Ophthalmology in China, 2021, 30(3): 200-203.
[5]	Liang Yuanbo, Lin Haishuang, Zhang Shaodan, Liu Chengtan, Xu Shuxia, Le Rongrong, Xie Yanqian, Li Guoxing. Trans-lens pressure difference and ciliary block—A new concept for the mechanism of angle closure glaucoma [J]. Ophthalmology in China, 2021, 30(2): 89-96.
[6]	Li Qiyan, Chen Xiaoli, Zheng Pengfei, Tang Xin. Treatment efficacy of endoscopic cyclophotocoagulation on post-traumatic refractory glaucoma [J]. Ophthalmology in China, 2021, 30(2): 142-146.
[7]	Yang Xue, Yu Xiaowei, Fan Zhigang. New insights into immune mechanisms in primary open angle glaucoma [J]. Ophthalmology in China, 2021, 30(1): 5-10.
[8]	Li Sizhen, Guo Chunyu, Liang Yuanbo, Fan Sujie, Cai Xiaogu, Sun Xia, Guo Lixia, Sun Lanping, SUCIJANTI, Han Wei, Wang Ningli . Five years’ results of LPI on acute primary angle closure glaucoma and PAS extent influence evaluation [J]. Ophthalmology in China, 2021, 30(1): 11-19.
[9]	Wang Huaizhou, Xin Chen, Shi Yan, Li Meng, Wang Ningli. Comparison of the efficacy and safety of ab externo microcatheter-assisted trabeculotomy for juvenile open-angle glaucoma and primary open angle glaucoma [J]. Ophthalmology in China, 2021, 30(1): 20-24.
[10]	Wang Rujie, Pan Weihua. Application of soft separation on the early bleb encapsulation separation after Ahmed glaucoma valve implantation [J]. Ophthalmology in China, 2021, 30(1): 25-29.
[11]	Lin Haishuang, Ye Cong, Huang Qiangjie, Wang Xiaojie, Zhou Wenzhe, Zhang Shaodan, XieYanqian, Xu Shuxia, Le Rongrong, Liang Yuanbo. Preliminary reports of low dose trans-scleral cycloplasty in acute angle closure glaucoma [J]. Ophthalmology in China, 2021, 30(1): 30-35.
[12]	Fan Wenying, Liu Ningpu. Meta-analysis of association between EPO gene polymorphisms and diabetic retinopathy [J]. Ophthalmology in China, 2020, 29(6): 454-457.
[13]	Xiao Hui, Luo Jingyi, Zhong Yimin, Liao Lingling, Wu Nina, Ling Yunlan, Liu Xing. Clinical characteristics of autosomal recessive bestrophinopathy associated with angle-closure glaucoma [J]. Ophthalmology in China, 2020, 29(5): 370-374.
[14]	Yu Xiaowei, Yang Xue, Zhao Zhenni, Fan Zhigang. New concepts to explore the pathogenesis and pathogenic genes of primary angle-closure glaucoma [J]. Ophthalmology in China, 2020, 29(4): 246-254.
[15]	Yin Peng, Shi Yan, Wang Yiwei, Wang Huaizhou, Xin Chen, Cao Kai, Wan Yue, Wang Ningli. Comparison of short-term efficacy of gonioscopy-assisted ab interno canaloplasty combined with transluminal trabeculotomy and standard gonioscopy-assisted transluminal trabeculotomy [J]. Ophthalmology in China, 2020, 29(4): 304-308.

Main problems and countermeasures of ophthalmic artificial intelligence research

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments